Table 4 Different outcome in the studied groups

Number of patients with seizures during trteatment: N (%)

8 (20%)

15 (37.5%)

0.04

Type of seizures: N (%)

 -No seizure

32 (80%)

25 (62.5%)

0.092

 -Focal

2 (5%)

4 (10%)

 -GTCs

6 (15%)

7 (17.5%)

 -Focal clonic

0 (0%)

1 (2.5%)

 -Myoclonic

0 (0%)

1 (2.5%)

 - Clonic

0 (0%)

1 (2.5%)

- Focal & GTCs

0 (0%)

1 (2.5%)

Seizure duration (min)

2 (0.2 – 15.0)

6 (1 – 15.0)

0.02

Number of patients with post discharge seizure

2 (5.0%)

11 (27.5%)

0.006

Duration of NICU stay (days)

25.58 ± 9.36

34.43 ± 13.53

0.001

Number of patients who needed inotropes

9 (22.5%)

20 (50%)

0.011

Duration of inotropes(hours)

12.0 (1.0 – 72.0)

24.0 (3.0 – 96.0)

0.032

Duration of MV (days)

10.85 ± 3.21

21.50 ± 6.64

 < 0.001

Cranial US on discharge: N (%)

-Normal

- Abnormal

32 (80%)

4 periventricular leukoencephalopathy (10%)

4 periventricular leukomalacia (10%)

22 (55%)

9 periventricular leukoencephalopathy (22.5%)

8 periventricular leukomalacia (20%)

1 cortical atrophy (2.5%)

0.006

MRI brain on discharge: N (%)

-Normal

- Abnormal

30 (75%)

4 periventricular leukoencephalopathy (10%)

4 periventricular leukomalacia (10%)

2 cortical atrophy (5%)

(1 of them had caudate nucleus changes)

19 (47.5%)

21 (52.5%)

9 periventricular leukoencephalopathy (22.5%)

8 periventricular leukomalacia (20%)

4 cortical atrophy (10%)

(1 of them had focal changes in the lateral thalamus and lentiform nucleus)

0.001